Oral polio vaccines: A matter for debate

Future Microbiology

Volumn 3, Issue 4, 2008, Pages 383-385

  Singh, Sunit K ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; PROTEIN VP1;

CHILDHOOD MORTALITY; DEVELOPING COUNTRY; DRUG TREATMENT FAILURE; EDITORIAL; EPIDEMIC; GENETIC DRIFT; GENETIC RECOMBINATION; HEALTH PROGRAM; HUMAN; INDIA; MASS IMMUNIZATION; NIGERIA; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RISK REDUCTION; SEROTYPE; VACCINATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

HUMANS; IMMUNIZATION PROGRAMS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 48749084970     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.4.383     Document Type: Editorial

References (9)

1. Minor PD: Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis. Expert Rev. Mol. Mod. 1-17 (1999).
2. Kimman TG, Koopmans MP, van der Avoort HG: Ending polio immunization: when and how are we sure that the needle is out of the haystack? Vaccine 17 (7-8), 624-627 (1999).
3. Minor PD, Macadam AJ. Stone DM, Almond JW: Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21(4), 357-363 (1993).
4. CDC: Update on vaccine-derived polioviruses. MMWR Morb. Mortal. Wkly Rep. 55(40), 1093-1097 (2006).
5. Roberts L: Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns. Science 317 (5846), 1842 (2007).
6. Kew OM, Sutter RW, de Gourville EM. Dowdle WR, Pallansch MA: Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59, 587-635 (2005).
7. Mittal SK, Mathew JL: Polio eradication in India: the way forward. Indian J. Pediatr. 74(2), 153-160 (2007).
8. Hovi T, Cantell K, Huovilainen A et al.: Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1(8495), 1427-1432 (1986).
9. Zimmerman RK, Spann SJ: Poliovirus vaccine options. Am. Fam. Physician 59(1), 113-118, 125-126 (1999).